Genome-editing tool could increase cancer risk in cells, say researchers

More research needs to be done to understand whether CRISPR-Cas9 – molecular ‘scissors’ that make gene editing a possibility – may inadvertently increase cancer risk in cells, according to researchers from the University of Cambridge and the Karolinska Institutet.

We don’t want to sound alarmist, and are not saying that CRISPR-Cas9 is bad or dangerous. This is clearly going to be a major tool for use in medicine, so it’s important to pay attention to potential safety concerns
- Jussi Taipale

The team, led by Professor Jussi Taipale, now at the Department of Biochemistry, Cambridge, found that CRISPR-Cas9 triggers a mechanism designed to protect cells from DNA damage, making gene editing more difficult. Cells which lack this mechanism are easier to edit than normal cells. This can lead to a situation where genome-edited cell populations have increased numbers of cells in which an important mechanism protecting cells against DNA damage is missing.

Discovered in bacteria, the CRISPR-Cas9 system is part of the armoury that bacteria use to protect themselves from the harmful effects of viruses. Today it is being co-opted by scientists worldwide as a way of removing and replacing gene defects.

One part of the CRISPR-Cas9 system acts like a GPS locator that can be programmed to go to an exact place in the genome. The other part – the ‘molecular scissors’ – cuts both strands of the faulty DNA so that it can be replaced with DNA that does not have the defect.

However, in a study published today in the journal Nature Medicine, researchers found unexpected consequences from using CRISPR-Cas9.

Read the full story

Image: Scissors cut metal

Credit: ulleo

Reproduced courtesy of the University of Cambridge



Looking for something specific?